0616 Immuniz
date post
07-May-2015Category
Documents
view
863download
8
Embed Size (px)
Transcript of 0616 Immuniz
- 1.Immunization Abdul Ghaffar Microbiology and Immunology
2. Milestones in immunization
- 1500BC
- Turks introduce variolation
- 3000BC
- Evidence of sniffing powdered small pox crust in Egypt
- 2000BC
- Sniffing of small pox crust in China
- 1700AD
- Introduction of variolation in England and later in the US
3.
- The wife of the British Ambassador in
- Turkey, in March 1717 wrote, following
- the variolation of her son, to a friend in
- England: The small pox, so fatal, so general
- amongst us, is entirely harmless here
- by the invention of ingrafting.I am
- patriot enough to bring this invention into
- fashion in England.
Introduction of variolation 4. Milestones in immunization
- 1780AD
- Edward Jenner discovers small pox vaccine
5. Edward Jenner Discovery of small pox vaccine 6. Edward Jenner Among patients awaiting small pox vaccination 7. Modern era of the vaccine
- 1920s
- Diphtheria and Tetanus
- 1934
- Pertussis
- 1955
- Salk polio
- 1885
- Rabies vaccine (Pasteur)
8. Modern era of the vaccine
- 1960s
- Mumps measles and rubella virus
- Sabin polio
- 1990s
- Hepatitis and varicella
- 1985
- Haemophilus
9. Pre- & post-vaccine incidence of common preventable diseases 10. Different modes of acquiring immunity Immunity Natural resistance Artificial Natural Passive Artificial Natural Active Acquired 11. Passive Immunity
- Colostral transfer of IgA
- Placental transfer of IgG
- Antibodies or immunoglobulins
- Immune cells
Natural Artificial 12. Passive Immunization disease indication antibody source human, horse diphtheria, tetanus prophylaxis, therapy vericella zoster human immunodeficiencies gas gangrene, botulism, snake bite, scorpion sting horse post-exposure rabies, human post-exposure hypogamma-globulinemia human prophylaxis 13. Advantages and Disadvantages of Passive Immunization
- serum sickness
- immediate protection
- no long term protection
- graft vs. host disease ( cell graft only )
- risk of hepatitis and Aids
Advantages Disadvantages 14. Active Immunization
- exposure to sub-clinical infections
- Attenuated organisms
- killed organisms
- sub-cellular fragments
- toxins
- others
Natural Artificial 15. Live Attenuated Vaccines
- tuberculosis
- not used in this country
- polio*
- not used in std. schedule
- measles, mumps & rubella
- yellow fever
- Military and travelers
- Varicella zoster
- children with no history of chicken pox
- hepatitis A
- not required in SC
16. Killed Whole-Organism Vaccines
- polio
- influenza
- elderly and at risk
- typhoid, cholera, plague
- epidemics and travelers
- rabies
- post exposure
- pertussis
- replaced by the acellular vaccine
- Q fever
- population at risk
17. Microbial Fragment Vaccines
- Bordetella. Pertussis
- virulence factor protein
- Haemophilus influenzae B
- protein conjugated polysaccharide
- Streptococcus pneumoniae
- Polysaccharide mixture
- Neisseria meningitidis
- polysaccharide
18. Microbial Fragment Vaccines
- Clostridiumtetani (tetanus)
- inactivated toxin (toxoid)
- Corynebacterium diphtheriae
- inactivated toxin (toxoid)
- Vibrio cholerae
- toxin subunits
- Hepatitis B virus
- cloned in yeast
19. Modification of Toxin to Toxoid Toxin toxin moiety antigenic determinants chemical modification Toxoid 20.
- anti-Idiotype Vaccine
Future Vaccines
- Immuno-dominant peptide
- DNA
21. Recommended Childhood Immunization Schedule 22. Adverse Events Occurring Within 48 Hours DTP of Vaccination Event Frequency
- local
- redness, swelling, pain
1 in 2-3 doses
- systemic: Mild/moderate
- fever, drowsiness, fretfulness vomiting
- anorexia
1 in 2-3 doses 1 in 5-15 doses
- systemic: more serious
- persistent crying, fever
- collapse, convulsions
- acute encephalopathy
- permanent neurological deficit
1 in 100-300 doses 1 in 1750 doses 1 in 100,000 doses 1 in 300,000 doses